Evidence map›Paper›PMID 41591154›Full record

ArticleToxins2025

Study on the Competitive Substitution of Four Polyphenolic Compounds on the HSA-Bound α-Zearalenol In Vitro Simulated Modeling.

Cheng Chen, Lu Chen, Hongyuan Zhou, Xiao Li Shen, Liang Ma

Abstract read
In one paragraph

Article in Toxins, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Cheng ChenSchool of Public Health, Zunyi Medical University, Zunyi 563000, China.ORCID 0009-0002-5349-2363
Lu ChenCollege of Food Science, Southwest University, Chongqing 400715, China.
Hongyuan ZhouCollege of Food Science, Southwest University, Chongqing 400715, China.ORCID 0000-0002-3734-7126
Xiao Li ShenSchool of Public Health, Zunyi Medical University, Zunyi 563000, China.ORCID 0000-0001-6270-997X
Liang MaCollege of Food Science, Southwest University, Chongqing 400715, China.

Funding

Joint Funds of the National Natural Science Foundation of China U22A20551
6 · The paper itself

Abstract

α-Zearalenol (α-ZOL), the primary metabolite of zearalenone (ZEN), is a prevalent mycotoxin in agricultural products (e.g., corn, wheat) and poses health risks due to its toxicity. However, strategies to mitigate its toxicity are needed. Therefore, this study aims to determine whether selected polyphenols (quercetin, baicalin, rosmarinic acid, naringenin) can competitively displace α-ZOL from human serum albumin (HSA) and to clarify the interaction mechanisms. The results showed that competitive interactions between α-ZOL, HSA, and the polyphenols were observed. The polyphenols bound HSA more tightly than α-ZOL (higher

Indexed as

PolyphenolsZeranolHumansProtein BindingSerum Albumin, HumanPolyphenolsSerum Albumin, HumanzearalenolZeranolbinding constantcompetitive substitutionhuman serum albuminpolyphenolic compoundsα-zearalenol

Identifiers

PMID41591154
PMCPMC12846070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.